AA-negative and Kappa-positive Amyloidosis in a Patient with Rheumatoid Arthritis

  • Ueno Toshiharu
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Sumida Keiichi
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Hoshino Junichi
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Suwabe Tatsuya
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Mise Koki
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Hazue Ryo
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Hayami Noriko
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Hiramatsu Rikako
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Kawada Masahiro
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Imafuku Aya
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Hasegawa Eiko
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Sawa Naoki
    Nephrology Center, Toranomon Hospital Kajigaya, Japan
  • Takaichi Kenmei
    Nephrology Center, Toranomon Hospital Kajigaya, Japan Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan
  • Kinowaki Keiichi
    Department of Pathology, Toranomon Hospital, Japan
  • Ohashi Kenichi
    Department of Pathology, Toranomon Hospital, Japan
  • Fujii Takeshi
    Department of Pathology, Toranomon Hospital, Japan
  • Nishida Aya
    Department of Hematology, Toranomon Hospital Kajigaya, Japan
  • Ubara Yoshifumi
    Nephrology Center, Toranomon Hospital Kajigaya, Japan Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Japan

この論文をさがす

抄録

<p>A 57-year-old Japanese woman with a 5-year history of rheumatoid arthritis (RA) was admitted to our hospital for an evaluation of nephrotic range proteinuria (4.8 g/day). A renal biopsy led to the diagnosis of amyloidosis according to strong positivity for Congo red staining and the detection of microfibrillar structures on electron microscopy that were negative for AA and positive for kappa light chain. Combination therapy with high-dose melphalan and autologous stem cell transplantation was performed according to the regimen for AL amyloidosis. Her proteinuria and RA subsided, but relapsed after 3 years. This is the first report regarding kappa light chain amyloidosis in an RA patient. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 55 (17), 2491-2495, 2016

    一般社団法人 日本内科学会

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ